https://www.parentproject.it/2018/10/05/catabasis-pharmaceuticals-inizia-il-trial-clinico-di-fase-3-polarisdmd-con-edasalonexent-nella-distrofia-muscolare-di-duchenne/ Insieme per fermare la Duchenne e la Becker Fri, 05 Oct 2018 09:10:45 +0000 hourly 1 https://wordpress.org/?v=6.9.4